Private Equity Fuels Fresh Momentum in US Protein Manufacturing

Pritzker’s NaturPak buy spotlights a quiet surge of capital into the factories that power protein-rich foods

20 Jan 2026

Private equity groups are increasingly investing in the industrial backbone of the food sector, betting that companies making protein-rich products will offer steadier returns than consumer brands. Pritzker Private Capital’s acquisition of NaturPak in January reflects that shift, as investors look beyond supermarket shelves to factory floors.

NaturPak produces shelf-stable foods including soups, sauces, bone broths and wet pet food. It mainly operates as a co-manufacturer, producing goods on behalf of brands and retailers that want to expand ranges quickly without committing capital to their own facilities. Financial terms of the deal were not disclosed.

Pritzker said it would retain NaturPak’s management team and invest in operations and innovation. The approach follows a familiar private equity model: support existing leadership, expand capacity and strengthen customer relationships. Such strategies have gained traction as protein has moved from a niche selling point to a routine feature of everyday diets, including pet nutrition.

The transaction also points to a broader recalibration in food investing. After years of backing consumer-facing brands vulnerable to changing tastes, investors are turning to manufacturing assets that offer scale, flexibility and more predictable cash flows. Co-manufacturers occupy a central position in the supply chain, serving multiple customers while managing regulatory and logistical demands.

For food companies, the availability of better-capitalised manufacturing partners can reduce risk. Investment in plant upgrades and automation can improve reliability and allow brands to grow without disruptions. For investors, protein-focused manufacturing is seen less as a trend-driven bet and more as essential infrastructure for the modern food system.

NaturPak’s change in ownership underscores how capital is reshaping the production of protein-rich foods in the US, even as consumers focus on branding, flavours and labels. The quiet consolidation of manufacturing assets suggests that the future of protein may depend as much on who makes it as on who markets it.